Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972616PMC
http://dx.doi.org/10.1590/s1807-59322010001000024DOI Listing

Publication Analysis

Top Keywords

missense tcf1
4
tcf1 mutation
4
mutation patient
4
patient mody-3
4
mody-3 liver
4
liver adenomatosis
4
missense
1
mutation
1
patient
1
mody-3
1

Similar Publications

Genetic studies in mice have shown that the zinc finger transcription factor BCL11B has an essential role in regulating early T cell development and neurogenesis. A de novo heterozygous missense BCL11B variant, BCL11B, was isolated from a patient with T cell deficiency and neurological disorders. Here, we show that mice harboring the corresponding Bcl11b mutation show the emergence of natural killer (NK)/group 1 innate lymphoid cell (ILC1)-like NKp46 cells in the thymus and reduction in TBR1 neurons in the neocortex, which are observed with loss of Bcl11a but not Bcl11b.

View Article and Find Full Text PDF

Adenomatous polyposis coli (APC) is a tumor suppressor protein commonly mutated in colorectal tumors. APC plays important roles in Wnt signaling and other cellular processes. Here, we present the crystal structure of the armadillo repeat (Arm) domain of APC, which facilitates the binding of APC to various proteins.

View Article and Find Full Text PDF

Maturity-onset diabetes of the young is a genetically heterogeneous autosomal dominant form of diabetes mellitus, characterized by an early age at onset and a primary defect in beta-cell function. Forty families with a clinical presentation suggestive of MODY were screened for the most common MODY subtypes caused by mutations in the genes encoding glucokinase (GCK, MODY2) and hepatocyte nuclear 1-alpha (HNF1A/TCF1, MODY3). Overall, 14 mutations were found (35%) giving a relative frequency of 22.

View Article and Find Full Text PDF

Bi-allelic inactivation of TCF1 in hepatic adenomas.

Nat Genet

October 2002

Inserm U434, Fondation Jean Dausset, 27 rue Juliette Dodu, 75010 Paris, France.

Article Synopsis
  • Liver adenomas are benign tumors that can turn malignant, and researchers discovered a specific deletion in chromosome 12q in several adenomas.
  • This deletion targets a region associated with the TCF1 gene, which is linked to a form of diabetes, suggesting that TCF1 may act as a tumor-suppressor gene.
  • The study found that inactivation of TCF1 is a significant genetic factor in liver adenoma development and could be an early indicator for some cases of hepatocellular carcinoma (HCC).
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!